A randomised placebo controlled trial of VSL#3® probiotic on biomarkers of cardiovascular risk and liver injury in non-alcoholic fatty liver disease

Pui Lin Chong*, David Laight, Richard J. Aspinall, Antony Higginson, Michael H. Cummings

*Corresponding author for this work

Research output: Contribution to journal › Article › peer-review

123 Downloads (Pure)

Fingerprint

Dive into the research topics of 'A randomised placebo controlled trial of VSL#3® probiotic on biomarkers of cardiovascular risk and liver injury in non-alcoholic fatty liver disease'. Together they form a unique fingerprint.

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science

INIS

Biochemistry, Genetics and Molecular Biology

Immunology and Microbiology